Skip to main content
. 2020 Aug 31;9(9):2822. doi: 10.3390/jcm9092822
ACA Anti-cardiolipin antibodies
ALT Alanine aminotransferase
AP Alkaline phosphatase
APS Antiphospholipid syndrome
AT-III Antithrombin III
BCLC Barcelona Clinic Liver Cancer
CT Computed tomography
EV Esophageal varices
FV factor V Leiden mutation
FVL Factor V Leiden
HCC Hepatocellular carcinoma
HE Hepatic encephalopathy
HIV Human immunodeficiency virus
INR International normalized ratio
JAK2 Janus Kinase 2 mutation
LA Lupus anticoagulant
LMWH Molecular-weight heparin
LT Liver transplantation
MELD Model for End-Stage Disease
MRI Magnetic resonance imaging
MTHFR Methylenetetrahydrofolate reductase TT677 genotype
PAI-1 Plasminogen activator inhibitor type 1
PNH Paroxysmal nocturnal hemoglobinuria
PTHR Prothrombin G20210A mutation
PV Polycythemia vera
PVT Portal vein thrombosis
RCT Randomized control trial
SBP Spontaneous bacterial peritonitis
SMV Superior mesenteric vei
SV Splenic vein
TIPS Transjugular intrahepatic portosystemic shunt
UK United Kingdom
US Ultrasound
VB Variceal bleeding